University Hospital and New Jersey Medical School (NJMS) are, through their joint FDA-approved convalescent plasma program, collecting plasma donations from patients who have recovered from COVID-19 and infusing it into patients still struggling to fight off the virus. Marc Klapholz, chair of NJMS” Department of Medicine and the hospital’s chief of medical service, explains that the presumed antibodies in the plasma may improve seriously ill patients’ chances for survival. To read the full article.
Recent Posts
- Join NJ ACTS Workforce Development Core for an NIH Fellowship Grant Writing Workshop this Fall
- NJACTS Community Engagement Core COVID-19 Resources
- NJACTS Community Engagement Core Available Services
- Unveiling the Biomechanical Forces that Drive Scarring.
- Scientists Discover Class of Crystals With Properties That May Prove Revolutionary.
Categories
- Community (2,291)
- Covid (988)
- CTO Events (6)
- News (2,917)
- Pilots (21)